Ayman Al-Bakri, Abdullah Al-Jaser, Khalid Al-Gamdi, Reshaid Al-Reshaid, Abdullah Al-Enizi, Ali Ali Al-Kharji, Ibrahim Al-Zahrani, Nawaf Al-Modahi, Moath Al-Harbi, Abdullah Al-Mani
{"title":"Safety of transurethral resection of large prostate.","authors":"Ayman Al-Bakri, Abdullah Al-Jaser, Khalid Al-Gamdi, Reshaid Al-Reshaid, Abdullah Al-Enizi, Ali Ali Al-Kharji, Ibrahim Al-Zahrani, Nawaf Al-Modahi, Moath Al-Harbi, Abdullah Al-Mani","doi":"10.4103/ua.ua_192_21","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Benign prostatic hyperplasia is a common benign disease occurs in older men. Some patients can be treated medically but eventually, most of them will need a surgical intervention, and the most commonly applied procedure is transurethral resection of the prostate (TURP).</p><p><strong>Objectives: </strong>The objective of this study is to assess the feasibility and safety of performing transurethral resection of large prostate (80 g and more).</p><p><strong>Methodology: </strong>Out of 153 patients reviewed 48 cases included in this study. The main data collected from patients' files and patient interview. The criteria of exclusion were prostate size <80 g and previous history of TURP. The collected data were analyzed by the Statistical Package for the Social Sciences (SPSS).</p><p><strong>Results: </strong>The main results showed that 93.7% of patients did not experience major bleeding postoperatively, neither major drop in hemoglobin level. Moreover, the patient's distribution according to the presence of TUR syndrome was only 2.1% with mild symptoms. No patient had an episode of retention during the hospital stay or in the follow-up.</p><p><strong>Conclusion: </strong>Surgeon experience, systematic resection approach, and strict time of resection are important factors to assure the safety of TURP in large prostate. In cases of huge prostate size >100 g, staged TURP can be offered safely or if patients' obstructive symptoms do not resolve after the first procedure.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"15 2","pages":"162-165"},"PeriodicalIF":0.7000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/88/UA-15-162.PMC10252772.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Annals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ua.ua_192_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/16 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Benign prostatic hyperplasia is a common benign disease occurs in older men. Some patients can be treated medically but eventually, most of them will need a surgical intervention, and the most commonly applied procedure is transurethral resection of the prostate (TURP).
Objectives: The objective of this study is to assess the feasibility and safety of performing transurethral resection of large prostate (80 g and more).
Methodology: Out of 153 patients reviewed 48 cases included in this study. The main data collected from patients' files and patient interview. The criteria of exclusion were prostate size <80 g and previous history of TURP. The collected data were analyzed by the Statistical Package for the Social Sciences (SPSS).
Results: The main results showed that 93.7% of patients did not experience major bleeding postoperatively, neither major drop in hemoglobin level. Moreover, the patient's distribution according to the presence of TUR syndrome was only 2.1% with mild symptoms. No patient had an episode of retention during the hospital stay or in the follow-up.
Conclusion: Surgeon experience, systematic resection approach, and strict time of resection are important factors to assure the safety of TURP in large prostate. In cases of huge prostate size >100 g, staged TURP can be offered safely or if patients' obstructive symptoms do not resolve after the first procedure.